Latest news
Loading news…
Novolytics
ClosedOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 MediumHeat score — how much recent activity & attention the company has (web traffic, news, hiring). Chorley, Lancashire, United Kingdom Founded 2002 For Profit
Novolytics is developer of bacteriophage-based therapeutics.
Novolytics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Novolytics was acquired by AmpliPhi Biosciences in 2016.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
Patents
3
About Novolytics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 2
- Active products
- 5
- Patents granted
- 3
- Trademarks
- 0
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $8.82M
Company Info
- Founded
- 2002
- Operating status
- Closed
- Company type
- For Profit
- Org types
- company
- HQ
- Chorley, Lancashire, United Kingdom
- Region
- Europe, Middle East, and Africa (EMEA)
- Exit date
- Jan 8, 2016
Signals & Scores
- Heat score
- Medium
- Trend (7d)
- -0.3
- Trend (30d)
- 4.2
- Trend (90d)
- 7.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Novolytics
Loading news…
FAQs about Novolytics
People who checked this page also checked these
Browse the full Acquirezy directory.